The ALS Association/Northeast ALS Consortium PALS Webinar
NurOwn® Clinical Development Program: Promising Phase 2 Results, Phase 3 Study Overview, and Hospital Exemption Program Update
lab_worker_woman.jpg
Monday, July 17, 2017
    1:00 - 2:00 PM EDT

Please join us for an upcoming research webinar about the NurOwn® Clinical Development Program. On July 17th, we will be joined by Robert Brown, MD, DPhil, University of Massachusetts, Merit Cudkowicz, MD, MSc, Massachusetts General Hospital, Anthony Windebank, MD, Mayo Clinic, Ralph Kern, MD, MHSc, BrainStorm Cell Therapeutics and Chaim Lebovits, BrainStorm Cell Therapeutics.

Agenda:
a. Introductions
b. Phase 2 study: promising efficacy and safety results
c. Phase 3 study: design, protocol, timelines, participating centers and investigators
d. NurOwn® Hospital Exemption Program Update
e. Q&A 
Northeast ALS Consortium | 855-437-4823 | alstrials@neals.org | www.neals.org